OverviewSuggest Edit

tella is a company that focuses on the research and development of regenerative and cellular medicine, including dendritic cell vaccine therapy. It is also engaged in the development of new cancer antigens, immunotherapies, and cell processing devices. In addition, the company provides medical institutions with technical and operational support for cell cultivation.
TypePublic
Founded2004
Websitetella.jp

Latest Updates

Employees (est.) (Apr 2020)35
Share Price (Jul 2021)¥212(+2%)
Cybersecurity ratingCMore

tella Financials and Metrics

tella Revenue

Market capitalization (21-Jul-2021)

5.4b

Closing stock price (21-Jul-2021)

212.0
tella's current market capitalization is ¥5.4 b.
Show all financial metrics

tella Cybersecurity Score

Cybersecurity ratingPremium dataset

C

74/100

SecurityScorecard logo

tella Online and Social Media Presence

Embed Graph

tella News and Updates

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. (“tella”) to collaborate…

One Letter Away, But 789% Returns: Japan Investors Buy Tella, Not Tesla

One Letter Away, But 789% Returns: Japan Investors Buy Tella, Not Tesla

tella Frequently Asked Questions

  • When was tella founded?

    tella was founded in 2004.

  • How many employees does tella have?

    tella has 35 employees.

  • Who are tella competitors?

    Competitors of tella include Luye Pharma, Karo Pharma and MolMed.